Related Experiment Videos
Chemotherapy and neutropenia
1Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Hematology/Oncology Clinics of North America
|April 1, 1996
Summary
Chemotherapy can cause myelosuppression, leading to neutropenia. Advances in understanding neutrophil biology and cytokine support improve recovery for cancer patients.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Myelosuppression is a common chemotherapy side effect.
- Neutropenia increases infection risk in cancer patients.
- Recent advances enhance understanding of neutrophil biology.
Purpose of the Study:
- Discuss neutrophil production.
- Present clinical development of hematopoietic cytokines.
- Highlight translational research in hematologic recovery.
Main Methods:
- Review of neutrophil biology.
- Analysis of chemotherapy-induced neutropenia.
- Clinical development of hematopoietic cytokines.
Main Results:
- Improved understanding of neutrophil production.
- Development of cytokine therapies for neutropenia.
- Successful translational research models.
Conclusions:
- Cytokine and progenitor cell support aids hematologic recovery.
- Novel therapeutic initiatives for cancer and hematologic malignancies.
- Continued research in neutrophil biology and cytokine therapy is crucial.